{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T09:59:49Z","timestamp":1648720789758},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2002,7,1]],"date-time":"2002-07-01T00:00:00Z","timestamp":1025481600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Cardiol Rep"],"published-print":{"date-parts":[[2002,7]]},"DOI":"10.1007\/s11886-002-0067-8","type":"journal-article","created":{"date-parts":[[2007,5,19]],"date-time":"2007-05-19T19:37:35Z","timestamp":1179603455000},"page":"313-319","source":"Crossref","is-referenced-by-count":1,"title":["Glycoprotein IIb\/IIIa receptor inhibitor-thrombolytic combination therapy for acute myocardial infarction"],"prefix":"10.1007","volume":"4","author":[{"given":"Ara M.","family":"Maranian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven R.","family":"Steinhubl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"67_CR1","first-page":"1238","volume":"28","author":"TJ Ryan","year":"1996","unstructured":"Ryan TJ, Anderson JL, Antman EM, et al.: ACC\/AHA guidelines for the management of patients with acute myocardial infarction. J Am Coll Cardiol. 1996, 28:1238\u20131428.","journal-title":"J Am Coll Cardiol"},{"key":"67_CR2","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/clc.4960120704","volume":"12","author":"J Herlitz","year":"1989","unstructured":"Herlitz J, Blohm M, Hartforrd M, et al.: Delay time in suspected acute myocardial infarction and the importance of its modification. Clin Cardiol. 1989, 12:370\u2013374.","journal-title":"Clin Cardiol"},{"key":"67_CR3","volume-title":"Morbidity and Mortality: Chartbook on Cardiovascular, Lung and Blood Diseases","author":"National Heart, Lung, and Blood Institute","year":"1992","unstructured":"National Heart, Lung, and Blood Institute: Morbidity and Mortality: Chartbook on Cardiovascular, Lung and Blood Diseases. Bethesda, MD: US Department of Health and Human Services, Public Health Service, National Institutes of Health; 1992."},{"key":"67_CR4","first-page":"397","volume":"1","author":"Gruppo Italiano per lo Studio della Streptochinasi nell\u2019Infarto Miocardio (GISSI)","year":"1986","unstructured":"Gruppo Italiano per lo Studio della Streptochinasi nell\u2019Infarto Miocardio (GISSI): Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet. 1986, 1:397\u2013401.","journal-title":"Lancet"},{"key":"67_CR5","first-page":"349","volume":"2","author":"ISIS-2 (Second International Study of Infarct Survival) Collaborative Group","year":"1988","unstructured":"ISIS-2 (Second International Study of Infarct Survival) Collaborative Group: Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. Lancet. 1988, 2:349\u2013360. A large randomized trial that established the benefit of combined antiplatelet and fibrinolytic therapy in treatment of AMI.","journal-title":"Lancet"},{"key":"67_CR6","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1056\/NEJM199309023291001","volume":"329","author":"The GUSTO Investigators","year":"1993","unstructured":"The GUSTO Investigators: An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 1993, 329:673\u2013682.","journal-title":"N Engl J Med"},{"key":"67_CR7","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1056\/NEJM199710163371603","volume":"337","author":"The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO III) Investigators","year":"1997","unstructured":"The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO III) Investigators: A comparison of reteplase with alteplase for acute myocardial infarction. N Engl J Med 1997, 337:1118\u20131123.","journal-title":"N Engl J Med"},{"key":"67_CR8","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/S0140-6736(99)07403-6","volume":"354","author":"ASSENT-2 (Assessment of the Safety and Efficacy of a New Thrombolytic) Investigators","year":"1999","unstructured":"ASSENT-2 (Assessment of the Safety and Efficacy of a New Thrombolytic) Investigators: Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomized trial. Lancet 1999, 354:716\u2013722.","journal-title":"Lancet"},{"key":"67_CR9","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1001\/jama.1993.03510100061033","volume":"270","author":"WD Weaver","year":"1993","unstructured":"Weaver WD, Cerqueira M, Hallstron AP, et al.: Prehospital-initiated vs. hospital-initiated thrombolytic therapy: the Myocardial Infarction Triage and Intervention Trial. JAMA. 1993, 270:1211\u20131216.","journal-title":"JAMA"},{"key":"67_CR10","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1056\/NEJM198511283132204","volume":"313","author":"G Koren","year":"1985","unstructured":"Koren G, Weiss AT, Hasin Y, et al.: Prevention of myocardial damage in acute myocardial ischemia by early treatment with intravenous streptokinase. N Engl J Med 1985, 313:1384\u20131389.","journal-title":"N Engl J Med"},{"key":"67_CR11","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/0140-6736(92)93003-6","volume":"340","author":"WT Hermens","year":"1992","unstructured":"Hermens WT, Willems GM, Nijssen KM, et al.: Effect of thrombolytic treatment delay on myocardial infarct size [letter]. Lancet. 1992, 340:1297.","journal-title":"Lancet"},{"key":"67_CR12","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1056\/NEJM199311253292204","volume":"329","author":"The GUSTO Angiographic Investigators","year":"1993","unstructured":"The GUSTO Angiographic Investigators: The effects of tissue plasminogen acitivator, streptokinase, or both on coronaryartery patency, ventricular function, and survival after acute myocardial infarction. N Engl J Med 1993, 329:1615\u20131622.","journal-title":"N Engl J Med"},{"key":"67_CR13","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/0002-9149(94)90552-5","volume":"74","author":"CB Granger","year":"1994","unstructured":"Granger CB, White HD, Bates ER, et al.: A pooled analysis of coronary arterial patency and left ventricular function after intravenous thrombolysis for acute myocardial infarction. Am J Cardiol. 1994, 74:1220\u20131228.","journal-title":"Am J Cardiol"},{"key":"67_CR14","doi-asserted-by":"crossref","first-page":"27183","DOI":"10.1074\/jbc.272.43.27183","volume":"272","author":"TV Byzova","year":"1997","unstructured":"Byzova TV, Plow EF: Networking in the hemostatic system: integrin aIIIbb3 binds prothrombin and influences its activation. J Biol Chem. 1997, 272:27183\u201327188.","journal-title":"J Biol Chem"},{"key":"67_CR15","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1161\/01.CIR.83.3.937","volume":"83","author":"DC Gulba","year":"1991","unstructured":"Gulba DC, Barthels M, Westhoff-Bleck M, et al.: Increased thrombin levels during thrombolytic therapy in acute myocardial infarction. Relevance for the success of therapy. Circulation 1991, 83:937\u2013944.","journal-title":"Circulation"},{"key":"67_CR16","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1159\/000048975","volume":"1","author":"KP Callahan","year":"2001","unstructured":"Callahan KP, Malinin AI, Gurbel PA, et al.: Platelets and Thrombolysis: Cooperation or Contrariety? Heart Drug. 2001, 1:281\u2013290.","journal-title":"Heart Drug"},{"key":"67_CR17","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/0049-3848(93)90198-W","volume":"71","author":"Sr Torr-Brown","year":"1993","unstructured":"Torr-Brown Sr, Sobel BE: Attenuation of thrombolysis by release of plasminogen activator inhibitor type-1 from platelets. Thromb Res. 1993, 71:289\u2013300.","journal-title":"Thromb Res"},{"key":"67_CR18","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1161\/01.CIR.79.4.920","volume":"79","author":"IK Jang","year":"1989","unstructured":"Jang IK, Gold HK, Ziskind AA, et al.: Differential sensitivity erythrocyte-rich and platelet-rich arterial thrombi to lysis with recombinant tissue-type plasminogen activator: a possible explanation for resistance to coronary thrombolysis. Circulation 1989, 79:920\u2013928.","journal-title":"Circulation"},{"key":"67_CR19","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1136\/hrt.68.10.374","volume":"68","author":"G Rasmanis","year":"1992","unstructured":"Rasmanis G, Vesterqvist O, Green K, et al.: Evidence of increased platelet activation after thrombolysis in patients with acute myocardial infarction. Br Heart J. 1992, 68:374\u2013376.","journal-title":"Br Heart J"},{"key":"67_CR20","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1161\/01.CIR.77.1.142","volume":"77","author":"DJ Fitzgerald","year":"1988","unstructured":"Fitzgerald DJ, Catella F, Roy L, et al.: Marked platelet activation in vivo after intravenous streptokinase in patients with acute myocardial infarction. Circulation. 1988, 77:142\u2013150.","journal-title":"Circulation"},{"key":"67_CR21","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1016\/0735-1097(90)90327-L","volume":"16","author":"T Yasuda","year":"1990","unstructured":"Yasuda T, Gold HK, Leinbach Rc, et al.: Lysis of plasminogen activator-resistant platelet-rich coronary thrombus with combined bolus injection of recombinant tissue-type plasminogen activator and antiplatelet GP IIb\/IIIa antibody. J Am Coll Cardiol. 1990, 16:1728\u20131735.","journal-title":"J Am Coll Cardiol"},{"key":"67_CR22","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1172\/JCI113446","volume":"81","author":"T Yasuda","year":"1988","unstructured":"Yasuda T, Gold HK, Fallon JT, et al.: Monoclonal antibody against the platelet glycoprotein (GP) IIbIIIa receptor prevents coronary artery reocclusion after reperfusion with recombinant tissue-type plasminogen activator in dogs. J Clin Invest. 1988, 81:1284\u20131291.","journal-title":"J Clin Invest"},{"key":"67_CR23","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1161\/01.ATV.13.12.1837","volume":"13","author":"C Kohmura","year":"1993","unstructured":"Kohmura C, Gold HK, Yasuda T, et al.: Chimeric murine\/ human antibody Fab fragment directed against the platelet GPIIb\/IIIa receptor enhances and sustains arterial thrombolysis with recombinant tissue-type plasminogen activator in baboons. Arterioscler Thromb. 1993, 13:1837\u20131842.","journal-title":"Arterioscler Thromb"},{"key":"67_CR24","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/0735-1097(93)90041-X","volume":"22","author":"NS Kleiman","year":"1993","unstructured":"Kleiman NS, Ohman EM, Califf RM, et al.: Profound inhibition of platelet aggregation with monoclonal antibody 7E3 Fab after thrombolytic therapy: results of the thrombolysis and Angioplasty in Myocardial Infarction (TAMI) 8 pilot study. J Am Coll Cardiol. 1993, 22:381\u2013389.","journal-title":"J Am Coll Cardiol"},{"key":"67_CR25","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1161\/01.CIR.99.21.2720","volume":"99","author":"EM Antman","year":"1999","unstructured":"Antman EM, Guigliano RP, Gibson MS, et al.,for the TIMI 14 Investigators. Abciximab facilitates the rate and extent of Thrombolysis: results of the Thrombolysis in Myocardial Infarction (TIMI) 14 trial. Circulation. 1999, 99:2720\u20132732.","journal-title":"Circulation"},{"key":"67_CR26","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.1161\/01.CIR.101.24.2788","volume":"101","author":"Strategies for Patency Enhancement in the Emergency Department (SPEED) Group","year":"2000","unstructured":"Strategies for Patency Enhancement in the Emergency Department (SPEED) Group: Trial of abciximab with and without low-dose reteplase for acute myocardial infarction. Circulation 2000, 101:2788\u20132794.","journal-title":"Circulation"},{"key":"67_CR27","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1161\/01.CIR.95.4.846","volume":"95","author":"EM Ohman","year":"1997","unstructured":"Ohman EM, Kleiman NS, Gacioch G, et al.: for the IMPACTAMI Investigators. Combined accelerated tissue-plasminogen activator and platelet glycoprotein IIb\/IIIa integrin receptor blockade with Integrilin in acute myocardial infarction. Circulation 1997, 95:846\u2013854.","journal-title":"Circulation"},{"key":"67_CR28","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1053\/euhj.1999.2035","volume":"21","author":"E Ronner","year":"2000","unstructured":"Ronner E, van Kesteren HA, Zijnen P, et al.: Safety and efficacy of eptifibatide vs. placebo in patients receiving thrombolytic therapy with streptokinase for acute myocardial infarction: a phase II dose escalation, randomized, double-blind study. Eur Heart J. 2000, 21:1530\u20131536.","journal-title":"Eur Heart J"},{"key":"67_CR29","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0735-1097(01)01758-2","volume":"39","author":"SJ Brener","year":"2002","unstructured":"Brener SJ, Zeymer U, Adgey AA, et al., for the INTRO AMI Investigators: Eptifibatide and low-dose tissue plasminogen activator in acute myocardial infarction. J Am Coll Cardiol. 2002, 39:377\u2013386.","journal-title":"J Am Coll Cardiol"},{"key":"67_CR30","doi-asserted-by":"crossref","first-page":"r27","DOI":"10.1161\/01.CIR.0000013402.34759.46","volume":"105","author":"EM Antman","year":"2002","unstructured":"Antman EM, Louwerenbug HW, Baars HF, et al., for the ENTIRETIMI 23 Investigators: Enoxaparin as adjunctive antithrombin therapy for ST-elevation myocardial infarction. Circulation 2002, 105:r27-r34.","journal-title":"Circulation"},{"key":"67_CR31","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1016\/S0140-6736(00)05059-5","volume":"357","author":"GUSTO V Investigators","year":"2001","unstructured":"GUSTO V Investigators: Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb\/ IIIa inhibition: the GUSTO V randomised trial. Lancet. 2001, 357:1905\u20131914. One of two clinical trials to compare the efficacy and safety of fulldose thrombolytics with half-dose thrombolytics in combination with a GP IIb\/IIIa receptor inhibitor.","journal-title":"Lancet"},{"key":"67_CR32","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0140-6736(01)05775-0","volume":"358","author":"Assessment of the Safety and Efficacy of a new Thrombolytic Regimen (ASSENT-3) Investigators","year":"2001","unstructured":"Assessment of the Safety and Efficacy of a new Thrombolytic Regimen (ASSENT-3) Investigators: Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomized trial in acute myocardial infarction. Lancet. 2001, 358:605\u2013613. One of two clinical trials to compare the efficacy and safety of fulldose thrombolytics with half-dose thrombolytics in combination with a GP IIb\/IIIa receptor inhibitor.","journal-title":"Lancet"},{"key":"67_CR33","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1056\/NEJM198709033171001","volume":"317","author":"EJ Topol","year":"1987","unstructured":"Topol EJ, Califf RM, George BS, et al.: A randomized trial of immediate vs delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction: the TAMI trial. N Engl J Med 1987, 317:581\u2013588.","journal-title":"N Engl J Med"},{"key":"67_CR34","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1016\/S0735-1097(99)00444-1","volume":"34","author":"AM Ross","year":"1999","unstructured":"Ross AM, Coyne KS, Reiner JS, et al., for the PACT investigators: A randomized trial comparing primary angioplasty with a strategy of short-acting thrombolysis and immediate planned rescue angioplasty in acute myocardial infarction: the PACT trial. J Am Coll Cardiol. 1999, 34:1954\u20131962.","journal-title":"J Am Coll Cardiol"},{"key":"67_CR35","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1161\/01.CIR.98.8.734","volume":"98","author":"SJ Brener","year":"1998","unstructured":"Brener SJ, Barr LA, Burchenal JE, et al., for the Reopro and Primary PTCA Organization and Randomized Trial (RAPPORT) Investigators: Randomized, placebo-controlled trial of primary glycoprotein IIb\/IIIa blockade with primary angioplasty for acute MI. Circulation. 1998, 98:734\u2013741.","journal-title":"Circulation"},{"key":"67_CR36","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1056\/NEJM200106213442503","volume":"344","author":"G Montalescot","year":"2001","unstructured":"Montalescot G, Barragan P, Wittenberg O, for the ADMIRAL investigators: Platelet Glycoprotein IIb\/IIIa Inhibition with Coronary Stenting for Acute Myocardial Infarction. N Engl J Med 2001, 344:1895\u20131903.","journal-title":"N Engl J Med"}],"container-title":["Current Cardiology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-002-0067-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11886-002-0067-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-002-0067-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T23:55:53Z","timestamp":1559433353000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11886-002-0067-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,7]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2002,7]]}},"alternative-id":["67"],"URL":"https:\/\/doi.org\/10.1007\/s11886-002-0067-8","relation":{},"ISSN":["1523-3782","1534-3170"],"issn-type":[{"value":"1523-3782","type":"print"},{"value":"1534-3170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,7]]}}}